Current and future surgical approaches in the management of endometrial carcinoma

Future Oncology

Volumn 4, Issue 3, 2008, Pages 389-401

  Leitao Jr , Mario M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Endometrial carcinoma; Laparoscopy; Molecular staging; Panniculectomy; Para aortic lymphadenectomy; Pelvic lymphadenectomy; Radical hysterectomy; Surgical cytoreduction

Indexed keywords

ADVANCED CANCER; BRACHYTHERAPY; CANCER GRADING; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED SURGERY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE FREE SURVIVAL; ENDOMETRIUM CARCINOMA; HIGH RISK PATIENT; HISTOPATHOLOGY; HOSPITALIZATION; HUMAN; HYSTERECTOMY; INTRAOPERATIVE PERIOD; LAPAROSCOPIC SURGERY; LAPAROTOMY; LENGTH OF STAY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MEDICAL DECISION MAKING; METASTASIS POTENTIAL; MORBIDITY; OPERATION DURATION; OVERALL SURVIVAL; PERIOPERATIVE COMPLICATION; POSTOPERATIVE CARE; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; ROBOTICS; SALPINGOOOPHORECTOMY; SENTINEL LYMPH NODE; SURGEON; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; UTERUS SURGERY;

CLINICAL TRIALS AS TOPIC; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; LYMPH NODE EXCISION;

EID: 47249112118     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.4.3.389     Document Type: Review

References (77)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J. Clin. 57(1), 43-66 (2007).
2. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA Cancer J. Clin. 55(2), 74-108 (2005).
3. FIGO: Classification and staging of malignant tumors in the female pelvis. Int. J. Gynaecol. Obstet. 9, 172 (1971).
4. FIGO. Corpus cancer staging. Int. J. Gynaecol. Obstet. 28, 190 (1989).
5. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB: Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group Study. Cancer 60(8 Suppl.), 2035-2041 (1987).
6. Morrow CP, Bundy BN, Kurman RJ et al.: Relationship between surgical-pathologic risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group Study. Gynecol. Oncol. 40(1), 55-65 (1991).
7. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS: The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol. Oncol. 106(2), 282-288 (2007).
8. Barakat RR, Lev G, Hummer AJ et al.: Twelve-year experience in the management of endometrial cancer: a change in surgical and postoperative radiation approaches. Gynecol. Oncol. 105(1), 150-156 (2007).
9. Chi DS, Barakat RR, Palayekar MJ et al.: The incidence of pelvic lymph node metastasis by FIGO staging for patients with adequately surgically staged endometrial adenocarcinoma of endometrioid histology. Presented at: Society of Gynecologic Oncologists 38th Annual Meeting. San Diego, CA, USA, 3-7 March, 2007.
10. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC: Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am. J. Obstet. Gynecol. 182(6), 1506-1519 (2000).
11. Eltabbakh GH, Piver MS, Hempling RE, Shin KH: Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int. J. Radiat. Oncol. Biol. Phys. 38(2), 373-380 (1997).
12. Cragun JM, Havrilesky LJ, Calingaert B et al.: Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol. 23(16), 3668-3675 (2005).
13. Lutman CV, Havrilesky LJ, Cragun JM et al.: Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology. Gynecol. Oncol. 102(1), 92-97 (2006).
14. Kilgore LC, Partridge EE, Alvarez RD et al.: Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol. Oncol. 56(1), 29-33 (1995).
15. Chan JK, Urban R, Cheung MK et al.: Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer 109(12), 2454-2460 (2007).
16. Ayhan A, Taskiran C, Celik C et al.: Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer? Gynecol. Oncol. 86(3), 259-263 (2002).
17. Straughn JM Jr, Huh W, Kelly FJ et al.: Conservative management of stage I endometrial carcinoma after surgical staging. Gynecol. Oncol. 84(2), 194-200 (2002).
18. Straughn JM Jr, Huh WK, Orr JW Jr et al.: Stage IC adenocarcinoma of the endometrium: survival comparisons of surgically staged patients with and without adjuvant radiation therapy. Gynecol. Oncol. 89(2), 295-300 (2003).
19. Lukka H, Chambers A, Fyles A et al.: Adjuvant radiotherapy in women with stage I endometrial cancer: a systematic review. Gynecol. Oncol. 102(2), 361-368 (2006).
20. Fanning J: Long-term survival of intermediate risk endometrial cancer (stage IG3, IC, II) treated with full lymphadenectomy and brachytherapy without teletherapy. Gynecol. Oncol. 82(2), 371-374 (2001).
21. Daniel AG, Peters WA 3rd: Accuracy of office and operating room curettage in the grading of endometrial carcinoma. Obstet. Gynecol. 71(4), 612-614 (1988).
22. Malviya VK, Deppe G, Malone JM Jr, Sundareson AS, Lawrence WD: Reliability of frozen section examination in identifying poor prognostic indicators in stage I endometrial adenocarcinoma. Gynecol. Oncol. 34(3), 299-304 (1989).
23. Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG: Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet. Gynecol. 77(6), 954-956 (1991).
24. Larson DM, Johnson KK, Broste SK, Krawisz BR, Kresl JJ: Comparison of D&C and office endometrial biopsy in predicting final histopathologic grade in endometrial cancer. Obstet. Gynecol. 86(1), 38-42 (1995).
25. Obermair A, Geramou M, Gucer F et al.: Endometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy. Int. J. Gynecol. Cancer 9(5), 383-386 (1999).
26. Frumovitz M, Singh DK, Meyer L et al.: Predictors of final histology in patients with endometrial cancer. Gynecol. Oncol. 95(3), 463-468 (2004).
27. Eltabbakh GH, Shamonki J, Mount SL: Surgical stage, final grade, and survival of women with endometrial carcinoma whose preoperative endometrial biopsy shows well-differentiated tumors. Gynecol. Oncol. 99(2), 309-312 (2005).
28. Ben-Schachar I, Pavelka J, Cohn DE et al.: Surgical staging for patients presenting with grade 1 endometrial carcinoma. Obstet. Gynecol. 105(3), 487-493 (2005).
29. Case AS, Rocconi RP. Straugh JM Jr et al.: A prospective blinded evaluation of the accuracy of frozen section for the surgical management of endometrial cancer. Obstet. Gynecol. 108(6), 1375-1379 (2006).
30. Traen K, Holund B, Mogensen O: Accuracy of preoperative tumor grade and intraoperative gross examination of myometrial invasion in patients with endometrial cancer. Acta Obstet. Gynecol. Scand. 86(6), 739-741 (2007).
31. Frumovitz M, Slomovitz BM, Singh DK et al.: Frozen section analyses as predictors of lymphatic spread in patients with early-stage uterine cancer. J. Am. Coll. Surg. 199(3), 388-393 (2004).
32. Mariani A, Webb MJ, Keeney GL, Calori G, Podratz KC: Role of wide/ radical hysterectomy and pelvic node dissection in endometrial cancer with cervical involvement. Gynecol. Oncol. 83(1), 72-80 (2001).
33. Cohn DE, Woeste EM, Cacchio S et al.: Clinical and pathologic correlates in surgical stage II endometrial carcinoma. Obstet. Gynecol. 109(5), 1062-1067 (2007).
34. Cornelison TL, Trimble EL, Kosary CL: SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol. Oncol. 74(3), 350-355 (1999).
35. Sartori E, Gadducci A, Landoni F et al.: Clinical behavior of 203 stage II endometrial cancer cases: the impact of primary surgical approach and of adjuvant radiation therapy. Int. J. Gynecol. Cancer 11(6), 430-437 (2001).
36. Denschlag D, Tan L, Patel S, Kerim-Dikeni A, Souhami L, Gilbert L: Stage III endometrial cancer: preoperative predictability, prognostic factors, and treatment outcome. Am. J. Obstet. Gynecol. 196(6), 546.e1-e7 (2007).
37. Fujimoto T, Nanjyo H, Nakamura A et al.: Para-aortic lymphadenectomy may improve disease-related survival in patients with multipositive pelvic lymph node stage IIIc endometrial cancer. Gynecol. Oncol. 107(2), 253-259 (2007).
38. Mariani A, Dowdy SC, Cliby WA et al.: Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients. Gynecol. Oncol. 101(2), 200-208 (2006).
39. Moore DH, Fowler WC Jr, Walton LA, Droegemueller W: Morbidity of lymph node sampling in cancers of the uterine corpus and cervix. Obstet. Gynecol. 74(2), 180-184 (1989).
40. Arduino S, Leo L, Febo G, Tessarolo M, Wierdis T, Lanza A: Complications of pelvic and para-aortic lymphadenectomy in patients with endometrial cancer. Eur. J. Gynaec. Oncol. 18(3), 208-210 (1997).
41. Homesley HD, Kadar N, Barrett RJ, Lentz SS: Selective pelvic and periaortic lymphadenectomy does not increase morbidity in surgical staging of endometrial carcinoma. Am. J. Obstet. Gynecol. 167(5), 1225-1230 (1992).
42. Giannice R, Susini T, Ferrandina G et al.: Systematic pelvic and aortic lymphadenectomy in elderly gynecologic oncologic patients. Cancer 92(10), 2562-2568 (2001).
43. Berclaz G, Hanggi W, Kratzer-Berger A, Altermatt HJ, Greiner RH, Dreher E: Lymphadenectomy in high risk endometrial carcinoma stage I and II: no more morbidity and no need for external radiation. Int. J. Gynecol. Cancer 9(4), 322-328 (1999).
44. Larson DM, Johnson K, Olson KA: Pelvic and para-aortic lymphadenectomy for surgical staging of endometrial cancer: morbidity and mortality. Obstet. Gynecol. 79(6), 998-1001 (1992).
45. Franchi M, Ghezzi F. Riva C, Miglierina M, Buttarelli M, Bolis P: Postoperative complications after pelvic lymphadenectomy for the surgical staging of endometrial cancer. J. Surg. Oncol. 78(4), 232-240 (2001).
46. Mohan DS, Samuels MA, Selim MA et al.: Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol. Oncol. 70(2), 165-171 (1998).
47. Abu-Rustum NR, Alektiar K, Iasonos A et al.: The incidence of symptomatic lower-extremity lymphedema following treatment of uterine corpus malignancies: a 12-year experience at Memorial Sloan-Kettering Cancer Center. Gynecol. Oncol. 103(2), 714-718 (2006).
48. Leitao MM Jr, Chi DS: Operative management of primary epithetial ovarian cancer. Curr. Oncol. Rep. 9, 478-484 (2007).
49. Goff BA, Goodman A, Muntz HG, Fuller AF Jr, Nikrui N, Rice LW: Surgical stage IV endometrial carcinoma: a study of 47 cases. Gynecol. Oncol. 52(2), 237-240 (1994).
50. Chi DS, Welshinger M, Venkatraman ES, Barakat RR: The role of surgical cytoreduction in stage IV endometrial carcinoma. Gynecol. Oncol. 67(1), 56-60 (1997).
51. Bristow RE, Zerbe MJ, Rosenshein NB, Grumbine FC, Montz FJ: Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival. Gynecol. Oncol. 78(2), 85-91 (2000).
52. Ayhan A, TAskiran C, Celik C, Yuce K, Kucukali T: The influence of cytoreductive surgery on survival and morbidity in stage IVB endometrial cancer. Int. J. Gynecol. Cancer 12(5), 448-453 (2002).
53. Lambrou NC, Gomez-Marin O, Mirhashemi R et al.: Optimal surgical cytoreduction in patients with stage III and stage IV endometrial carcinoma: a study of morbidity and survival. Gynecol. Oncol. 93(3), 653-658 (2004).
54. van Wijk FH, Huikeshoven FJ, Abdulkadir L, Ewing PC, Burger CW: Stage III and IV endometrial cancer: a 20-year review of patients. Int. J. Gynecol. Cancer 16(4), 1648-1655 (2006).
55. Walker J, Piedmonte, Spirtos, N et al.: Phase III trial of laparoscopy (scope) vs laparotomy (open) for surgical resection and comprehensive surgical staging of uterine cancer: a Gynecologic Oncology Group (GOG) study funded by NCI. Presented at: Society of Gynecologic Oncologists 37th Annual Meeting. Palm Springs, CA, USA, 22-26 March, 2006.
56. Kornblith A, Walker J, Huang H, Cella D: Quality of life (QOL) of patients in a randomized clinical trial of laparoscopy (scope) vs open laparotomy (open) for the surgical resection and staging of uterine cancer: a Gynecologic Oncology Group (GOG) study. Presented at: Society of Gynecologic Oncologists 37th Annual Meeting. Palm Springs, CA, USA, 22-26 March, 2006.
57. Walker JL, Piedmonte M, Spirtos N et al.: Surgical staging of uterine cancer: randomized Phase III trial of laparoscopy vs laparotomy - a Gynecologic Ontology Group study (GOG): preliminary results. J. Clin. Oncol. 24, 18S (2006).
58. Frumovitz M, Ramirez PT, Greer M et al.: Laparoscopic training and practice in gynecologic oncology among Society of Gynecologic Oncologists members and fellows-in-training. Gynecol. Oncol. 94(3), 746-753 (2004).
59. Shafer A, Boggess JF, Gehrig P et al.: Type III radical hysterectomy for obese women with cervical carcinoma: robotic versus open. Gynecol. Oncol. 104, S14 (2007) (Abstract).
60. Boggess JF, Fowler WC Jr, Gehrig P et al.: Robotic assistance improves minimally invasive surgery for endometrial cancer. Gynecol. Oncol. 104, S52 (2007) (Abstract).
61. Eisenhauer EL, Wypych KA, Mehrara BJ et al.: Comparing surgical outcomes in obese women undergoing laparotomy, laparoscopy, or laparotomy with panniculectomy for the staging of uterine malignancy. Ann. Surg. Oncol. 14(8), 2384-2391 (2007).
62. Tillmanns TD, Kamelle SA, Abudayyeh I et al.: Panniculectomy with simultaneous gynecologic oncology surgery. Gynecol. Oncol. 83(3), 518-522 (2001).
63. Wright JD, Rosenbush EJ, Powell MA et al.: Long-term outcome of women who undergo panniculectomy at the time of gynecologic surgery. Gynecol. Oncol. 102(1), 86-91 (2006).
64. Blomfield PI, Le T, Allen DG, Planner RS: Panniculectomy: a useful technique for the obese patient undergoing gynecological surgery. Gynecol Oncol. 70(1), 80-86 (1998).
65. Hopkins MP, Shriner AM, Parker MG, Scott L: Panniculectomy at the time of gynecologic surgery in morbidly obese patients. Am. J. Obstet. Gynecol. 182(6), 1502-1505 (2000).
66. Powell JL, Kasparek DK, Connor GP: Panniculectomy to facilitate gynecologic surgery in morbidly obese women. Obstet. Gynecol. 94(4), 528-531 (1999).
67. Pearl ML, Valea FA, Chalas E: Panniculectomy and supraumbilical vertical midline incisions in morbidly obese gynecologic oncology patients. J. Am. Coll. Surg. 186(6), 649-653 (1998).
68. Wright JD, Powell MA, Herzog TJ et al.: Panniculectomy: improving lymph node yield in morbidly obese patients with endometrial neoplasms. Gynecol. Oncol. 94(2), 436-441 (2004).
69. Horowitz NS, Powell MA, Drescher CW et al.: Adequate staging for uterine cancer can be performed through Pfannenstiel incisions. Gynerol. Oncol. 88(3), 404-410 (2003).
70. Ayhan A, Dursun P, Gultekin M, Esin S: Pfannenstiel vs midline incision for early stage endometrial carcinoma. Int. J. Gynaecol. Obstet. 93(1), 67-69 (2006).
71. Frumovitz M, Bodurka DC, Broaddus RR et al.: Lymphatic mapping and sentinel node biopsy in women in high-risk endometrial cancer. Gynerol. Oncol. 104(1), 100-103 (2007).
72. Lopes LA, Nicolau SM, Baracat FF et al.: Sentinel lymph node in endometrial cancer. Int. J. Gynecol. Cancer 17(5), 1113-1117 (2007).
73. Delaloye J, Pampallona, S, Chardonnens E et al.: Intraoperative lymphatic mapping and sentinel node biopsy using hysteroscopy in patients with endometrial cancer. Gynecol. Oncol. 106(1), 89-93 (2007).
74. Niikura H, Okamoto S, Yoshinaga K et al.: Detection of micrometastases in the sentinel lymph nodes of patients with endometrial cancer. Gynecol. Oncol. 105(3), 683-686 (2007).
75. Barranger E, Cortez A, Grahek D, Callard P, Uzan S, Darai E: Laparoscopic sentinel node procedure using a combination of patent blue and radiocolloid in women with endometrial cancer. Ann. Surg. Oncol. 11 (3), 344-349 (2004).
76. Mariani A, Sebo TJ, Katzmann JA et al.: Endometrial cancer: can nodal status be predicted with curettage? Gynecol. Oncol. 96(3), 594-600 (2005).
77. Bell JG, Minnick A, Reid GC, Judis J, Brownell M: Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma. Gynecol. Oncol. 66(3), 388-392 (1997).